Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)
August 12, 2020
The infamous “Quarantine 15,” a reference to packing on the pounds during the pandemic, is affecting even the youngest of Americans, according to UT Physicians pediatricians, who are seeing the evidence in front of them via telemedicine appointments.
July 28, 2020
Stacey Crane, PhD, RN, will use a new grant from the St. Baldrick’s Foundation to pilot test a web-based interface designed to make it easier for kids with cancer and their parents to report symptoms in real time with the ultimate goal of improving kids’ outcomes. Crane is an assistant professor in the Department of Research at Cizik School of Nursing at The University of Texas Health Science Center at Houston (UTHealth Houston).
July 27, 2020
People who received at least one flu vaccination were 17% less likely to get Alzheimer’s disease over the course of a lifetime, according to researchers at The University of Texas Health Science Center at Houston (UTHealth).
July 22, 2020
Early rehabilitation of COVID-19 survivors is important to reduce long-term complications, according to researchers at The University of Texas Health Science Center at Houston (UTHealth).
July 17, 2020
A Harris Health LBJ patient credits a century-old treatment now being used to help coronavirus patients fight off the infection – convalescent blood plasma transfusions – with helping her recover.
July 14, 2020
Anjail Sharrief, MD, MPH, was appointed to a citywide COVID-19 response task force.
July 14, 2020
Physicians are studying whether vadadustat, an investigational therapy, could protect the lungs of COVID-19 patients by triggering the body’s protective response to low oxygen levels in a randomized Phase II clinical trial at UTHealth.
July 13, 2020
To accelerate colorectal cancer screening for the most vulnerable Texans, the U.S. Centers for Disease Control and Prevention (CDC) Colorectal Cancer Control Program has awarded The University of Texas Health Science Center at Houston (UTHealth) School of Public Health a $3.8 million grant.
July 13, 2020
An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann - Texas Medical Center and Harris Health System’s Lyndon B. Johnson Hospital.
June 22, 2020
A drug is being studied for its effectiveness in treating a type of severe immune overreaction seen in patients with COVID-19-induced pneumonia by researchers at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is enrolling patients at Harris Health System’s Lyndon B. Johnson Hospital.
Use the form below to perform a new search.